- Home
- AEHL vs SBFM Comparison
AEHL vs SBFM Comparison
Compare AEHL & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AEHL | SBFM |
|---|---|---|
| Founded | 1993 | 2006 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2M | 6.0M |
| IPO Year | 2009 | N/A |
Fundamental Metrics
Financial Performance| Metric | AEHL | SBFM |
|---|---|---|
| Price | $2.20 | $1.11 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 8.1M | 32.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $10.26 |
| Revenue Next Year | N/A | $32.63 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.09 | $1.12 |
| 52 Week High | $8.41 | $3.90 |
Technical Indicators
Market Signals| Indicator | AEHL | SBFM |
|---|---|---|
| Relative Strength Index (RSI) | 71.01 | 36.39 |
| Support Level | $1.80 | N/A |
| Resistance Level | $2.47 | $1.52 |
| Average True Range (ATR) | 0.25 | 0.04 |
| MACD | 0.19 | -0.00 |
| Stochastic Oscillator | 79.06 | 0.00 |
Price Performance
Historical ComparisonAbout AEHL Antelope Enterprise Holdings Limited
Antelope Enterprise Holdings Ltd operates in two reportable operating segments: 1) business management consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting, and 2) natural gas power generation, which was in the initial development stage. The business of the Company is engaged in the PRC and U.S.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.